COCHLEAR LIMITED Rule 3.19A.2
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Cochlear Limited
ABN 96 002 618 073We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of Director | Christopher Michael Smith |
Date of last notice | 15 September 2015 |
Part 1 - Change of director's relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of 'notifiable interest of a director' should be disclosed in this part.
Direct or indirect interest | Direct |
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. | Not applicable |
Date of change | Change 1: 22 October 2015 Change 2: 27 October 2015 |
No. of securities held prior to change |
|
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director's Interest NoticeClass |
|
Number acquired | Change 1: 12,531 Shares Mr Smith acquired the Shares by the exercise of 12,531 options granted to him under the Cochlear Long Term Incentive Plan ('CELTIP Option'). |
Number disposed | Change 2: 5,031 Shares sold following exercise of options in Change 1. |
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation | Change 1: $62.78 per Share Change 2: $84.50 per Share |
No. of securities held after change | 18,288 Shares 30,367 LTI Options 6,196 LTI Performance Rights 3,226 STI Performance Rights |
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back | Change 1: Exercise of options Change 2: On-market trade |
+ See chapter 19 for defined terms.
Appendix 3Y Page 2 01/01/2011
Appendix 3Y Change of Director's Interest NoticeNote: In the case of a company, interests which come within paragraph (ii) of the definition of 'notifiable interest of a director' should be disclosed in this part.
Detail of contract | Change 3: Mr Smith has entered into a financing transaction with a financier to fund the exercise of Options detailed in Part 1. As part of the security arrangements for this transaction, Mr Smith has acquired put options with the financier over Shares exercisable in the event the share price is below a nominated level in October 2016. |
Nature of interest | Direct |
Name of registered holder (if issued securities) | Christopher Michael Smith |
Date of change | Change 3: 21 October 2015 |
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed | 10,788 Shares |
Interest acquired | Refer to 'Detail of contract' above |
Interest disposed | Not applicable |
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation | A premium is payable to the financier for the transaction |
Interest after change | Financing arrangements relating to the acquisition of 18,288 Shares, including put options maturing in August and October 2016. |
Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? | No |
If so, was prior written clearance provided to allow the trade to proceed during this period? | Not applicable |
If prior written clearance was provided, on what date was this provided? | Not applicable |
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3
|
distributed by
|
